MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
LivaNova PLC DPO Ratio 2011-2026 | LIVN
Annual DPO Ratio LivaNova PLC
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68 | 68.7 | 71.2 | 82.6 | 78.5 | 85.8 | 92.4 | 75.2 | 87 | 64.8 | 268 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 268 | 64.8 | 94.7 |
Quarterly DPO Ratio LivaNova PLC
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70.8 | 70.2 | 74.7 | - | - | 69.2 | 81.7 | - | 76.3 | 79.2 | 76.6 | - | 38.9 | 48.3 | 90.3 | - | 65.6 | 62.2 | 73.8 | - | 70.4 | 99.1 | 51.4 | - | 91 | 105 | 88.1 | - | 74.2 | 76.1 | 87.7 | - | 89.3 | 93.3 | 90.1 | - | 79.7 | 64.9 | 74.8 | - | 1.05 K | 1.05 K | 658 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.05 K | 38.9 | 155 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ClearPoint Neuro
CLPT
|
33.2 | $ 8.99 | -4.16 % | $ 255 M |  USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.45 | -0.29 % | $ 129 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 12.01 | -0.5 % | $ 1.62 B | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
FONAR Corporation
FONR
|
16.6 | $ 18.6 | - | $ 122 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
46.4 | $ 36.14 | -1.65 % | $ 5.38 K | USA |
 |
Globus Medical
GMED
|
33.1 | $ 90.07 | 1.66 % | $ 12.2 B | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 1.78 | -6.32 % | $ 1.08 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 9.27 | -0.43 % | $ 714 M | USA |
 |
Inspire Medical Systems
INSP
|
103 | $ 54.06 | -0.15 % | $ 1.59 B | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
IRIDEX Corporation
IRIX
|
71.9 | $ 1.01 | 1.34 % | $ 17.1 M | USA |
 |
Integer Holdings Corporation
ITGR
|
28.9 | $ 85.48 | -0.18 % | $ 2.97 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 15.68 | -1.63 % | $ 368 M | USA |
 |
LENSAR
LNSR
|
146 | $ 5.83 | -1.1 % | $ 69.7 M | USA |
 |
Medtronic PLC
MDT
|
76.2 | $ 86.15 | -0.15 % | $ 111 B | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
Myomo
MYO
|
34.8 | $ 0.66 | -5.68 % | $ 27.6 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
33.7 | $ 166.53 | -3.11 % | $ 12.5 B | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Orthofix Medical
OFIX
|
76.3 | $ 11.68 | -0.76 % | $ 463 M |  Curacao |
 |
AxoGen
AXGN
|
34.4 | $ 30.86 | -5.45 % | $ 1.42 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
Penumbra
PEN
|
26.1 | $ 329.86 | - | $ 12.8 B | USA |
 |
Insulet Corporation
PODD
|
22.5 | $ 202.45 | -0.52 % | $ 14.2 B | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Sintx Technologies
SINT
|
223 | $ 2.53 | - | $ 7.02 M | USA |
 |
Butterfly Network
BFLY
|
51.3 | $ 4.03 | -2.54 % | $ 853 M | USA |
 |
Smith & Nephew plc
SNN
|
232 | $ 31.63 | -3.06 % | $ 23.8 B |  Britain |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Stryker Corporation
SYK
|
70.1 | $ 330.34 | -0.59 % | $ 126 B | USA |
 |
Cytosorbents Corporation
CTSO
|
107 | $ 0.59 | 0.76 % | $ 36.7 M | USA |
 |
Tactile Systems Technology
TCMD
|
24.4 | $ 24.31 | -1.06 % | $ 556 M | USA |
 |
TELA Bio
TELA
|
31.8 | $ 0.67 | 6.38 % | $ 31.5 M | USA |
 |
TransMedics Group
TMDX
|
15.5 | $ 106.65 | 1.77 % | $ 3.63 B | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
Tandem Diabetes Care
TNDM
|
35.7 | $ 19.31 | 0.74 % | $ 1.31 B | USA |
 |
Delcath Systems
DCTH
|
56 | $ 9.64 | -0.67 % | $ 345 M | USA |
 |
Boston Scientific Corporation
BSX
|
61.7 | $ 60.97 | -2.6 % | $ 90.3 B | USA |